Issuance of Stock Acquisition Rights
First written in FY2017-Q3. 16 of 23 entries say "Advanced", first in FY2018-Q2. Latest entry: 2026-08-17.
The whole theme swung hardest in 2026: 1 of 9 companies on the "Worse" side.
3 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The 46,000-share decrease in treasury common shares resulted from the exercise of stock options.」
The 46,000 stock options granted in 2022 were exercised, reducing treasury shares. The 31,000 share acquisition rights granted in 2025 have also been issued. - FY2026-H1AdvancedAnnual report
「Resolution date 24 July 2025 Categories and number of grantees (people) Company directors, excluding directors who are Audit and Supervisory Committee members and outside directors: 3 Company executive officers: 3 Number of share acquisition rights (units): ※ 31 (Note 1) Class, description and number of shares underlying the share acquisition rights (shares): ※ Common shares: 31,000 (Note 1) Exercise period: ※ 18 August 2028 to 17 August 2033」
The company issued 31 share acquisition rights covering 31,000 shares to 3 directors and 3 executive officers on 18 August 2025, setting the exercise period from 2028 to 2033. - FY2025-H1AdvancedAnnual report
「Resolution date 18 July 2024 Categories and number of grantees (people) Company directors, excluding directors who are Audit and Supervisory Committee members and outside directors: 3 Company executive officers: 3 Number of share acquisition rights (units): ※ 25 (Note 1) Class, description and number of shares underlying the share acquisition rights (shares): ※ Common shares: 25,000 (Note 1) Exercise period: ※ 16 August 2027 to 15 August 2032」
The company issued 25 share acquisition rights covering 25,000 shares to 3 directors and 3 executive officers on 16 August 2024, setting the exercise period from 2027 to 2032. - FY2024-Q3AdvancedAnnual report
「8 November 2023 (Note) This was an increase resulting from the exercise of share acquisition rights. The resulting increases of ¥2,539 thousand in stated capital and ¥2,539 thousand in capital surplus were transferred to other capital surplus pursuant to Articles 447 and 448 of the Companies Act.」
The exercise of share acquisition rights increased the total number of issued shares by 49,000 on 8 November 2023, and the resulting increases of ¥2,539 thousand each in stated capital and capital surplus were transferred to other capital surplus. - FY2024-Q2AchievedAnnual report
「Share acquisition rights issued during the second quarter of the current fiscal year were as follows. Resolution date 21 July 2023 Categories and number of grantees (people) Company directors, excluding directors who are Audit and Supervisory Committee members and outside directors: 3 Company executive officers: 3 Number of share acquisition rights (units): ※ 28 (Note 1) Class, description and number of shares underlying the share acquisition rights (shares): ※ Common shares: 28,000 (Note 1) Exercise period: ※ 16 August 2026 to 15 August 2031」
The 28 share acquisition rights resolved on 21 July 2023, covering 28,000 shares, were issued on 16 August 2023. - FY2024-Q1AdvancedAnnual report
「At a board of directors meeting held on 21 July 2023, the company resolved to issue share acquisition rights as stock options to its directors, excluding directors who are Audit and Supervisory Committee members and outside directors, and its executive officers, pursuant to Articles 236, 238 and 240 of the Companies Act and a resolution of the 196th annual general meeting of shareholders held on 24 June 2016.」
The company resolved to issue 28 share acquisition rights to 6 directors and executive officers, setting 16 August 2023 as the allotment date and the exercise period from 16 August 2026 to 15 August 2031. - FY2023AdvancedAnnual report
「The 134,000-share increase in the number of issued common shares resulted from the exercise of stock options.」
The exercise of stock options increased the number of issued shares by 134,000. - FY2023-Q3AdvancedAnnual report
「8 November 2022 (Note) This was an increase resulting from the exercise of share acquisition rights. The resulting increases of ¥5,779 thousand in stated capital and ¥5,779 thousand in capital surplus were transferred to other capital surplus pursuant to Articles 447 and 448 of the Companies Act.」
The exercise of share acquisition rights increased the number of issued shares by 134,000 on 8 November 2022, and the resulting increases of ¥5,779 thousand each in stated capital and capital surplus were transferred to other capital surplus. - FY2023-Q2AchievedAnnual report
「Share acquisition rights issued during the second quarter of the current fiscal year were as follows: number of share acquisition rights (units), 46; class, description and number of shares underlying the share acquisition rights, ※ common shares, 46,000; exercise payment (yen), ※ ¥1 per share; exercise period, ※ 16 August 2025 to 15 August 2030.」
The 46 share acquisition rights resolved on 21 July 2022, covering 46,000 shares, were issued on 16 August 2022. - FY2023-Q1AdvancedAnnual report
「At a board of directors meeting held on 21 July 2022, the company resolved to issue share acquisition rights as stock options to its directors, excluding directors who are Audit and Supervisory Committee members and outside directors, and its executive officers, pursuant to Articles 236, 238 and 240 of the Companies Act and a resolution of the 196th annual general meeting of shareholders held on 24 June 2016. 3. Total number of share acquisition rights 46 6. Exercise period for the share acquisition rights 16 August 2025 to 15 August 2030」
The company resolved to issue 46 share acquisition rights to 6 directors and executive officers, setting the exercise period from 2025 to 2030. - FY2022AdvancedAnnual report
「The 177,000-share increase in the number of issued common shares resulted from the exercise of stock options.」
The exercise of stock options increased the number of issued shares by 177,000, bringing the total number of issued shares to 30,177,000. - FY2022-Q2AchievedAnnual report
「Share acquisition rights issued during the second quarter of the current fiscal year were as follows: number of share acquisition rights (units), 44; class, description and number of shares underlying the share acquisition rights, ※ common shares, 44,000; exercise payment (yen), ※ ¥1 per share; exercise period, ※ 20 August 2024 to 19 August 2029.」
For the rights resolved on 27 July 2021, the company issued 44 share acquisition rights covering 44,000 shares to 3 directors and 3 executive officers on 20 August 2021. - FY2022-Q1AdvancedAnnual report
「At a board of directors meeting held on 27 July 2021, the company resolved to issue share acquisition rights as stock options to its directors, excluding directors who are Audit and Supervisory Committee members and outside directors, and its executive officers, pursuant to Articles 236, 238 and 240 of the Companies Act and a resolution of the 196th annual general meeting of shareholders held on 24 June 2016.」
The company resolved to issue 44 share acquisition rights to 6 directors and executive officers, setting 20 August 2021 as the allotment date and the exercise period from 20 August 2024 to 19 August 2029. - FY2021AdvancedAnnual report
「At a board of directors meeting held on 22 July 2020, the company resolved to issue share acquisition rights as stock options to its directors, excluding directors who are Audit and Supervisory Committee members and outside directors, and its executive officers, pursuant to Articles 236, 238 and 240 of the Companies Act and a resolution of the 196th annual general meeting of shareholders held on 24 June 2016.」
The company issued 44 share acquisition rights covering 44,000 shares to 3 directors and 3 executive officers. - FY2020-Q2AchievedAnnual report
「Share acquisition rights issued during the second quarter of the current fiscal year were as follows. Number of share acquisition rights (units): 73 Class, description and number of shares underlying the share acquisition rights: ※ Common shares: 73,000 Exercise payment (yen): ※ ¥1 per share Exercise period: ※ 20 August 2022 to 19 August 2027」
The 73 share acquisition rights resolved on 24 July 2019, covering 73,000 shares, were issued on 20 August 2019. - FY2020-Q1AdvancedAnnual report
「At a board of directors meeting held on 24 July 2019, the company resolved to issue share acquisition rights as stock options to its directors, excluding directors who are Audit and Supervisory Committee members and outside directors, and its executive officers, pursuant to Articles 236, 238 and 240 of the Companies Act and a resolution of the 196th annual general meeting of shareholders held on 24 June 2016.」
The company resolved to issue 73 share acquisition rights to 5 directors and executive officers, allotting them on 20 August 2019 and setting the exercise period from 20 August 2022 to 19 August 2027. - FY2019-Q2AchievedAnnual report
「Share acquisition rights issued during the second quarter of the current fiscal year were as follows: number of share acquisition rights (units), 81; class, description and number of shares underlying the share acquisition rights, common shares, 81,000; exercise payment (yen), ¥1 per share; exercise period, 20 August 2021 to 19 August 2026.」
The company issued 81 share acquisition rights covering 81,000 shares to directors and executive officers on 20 August 2018. - FY2019-Q1AdvancedAnnual report
「At a board of directors meeting held on 25 July 2018, the company resolved to issue share acquisition rights as stock options to its directors, excluding directors who are Audit and Supervisory Committee members and outside directors, and its executive officers, pursuant to Articles 236, 238 and 240 of the Companies Act and a resolution of the 196th annual general meeting of shareholders held on 24 June 2016. The total number of share acquisition rights was 81, with an exercise period from 20 August 2021 to 19 August 2026.」
The company resolved to issue 81 share acquisition rights for 5 directors and executive officers, with an exercise period from 2021 to 2026. - FY2018-Q2AdvancedAnnual report
「Share acquisition rights issued during the second quarter of the current fiscal year were as follows: number of share acquisition rights (units), 110; number of shares underlying the share acquisition rights, 110,000; exercise payment, ¥1 per share; exercise period, 20 September 2020 to 19 September 2025.」
The company newly issued 110 share acquisition rights covering 110,000 shares, with an exercise period from 20 September 2020 to 19 September 2025. - FY2017RestatedAnnual report
「The share acquisition rights issued pursuant to a resolution of the board of directors dated 9 November 2016 under the Companies Act comprised 80 rights covering 80,000 shares, with an exercise payment of ¥1 per share and an exercise period from 5 December 2019 to 4 December 2024.」
The terms of the share acquisition rights issued as stock options were also confirmed in the annual report. - FY2017-Q3First statedAnnual report
「Share acquisition rights issued during the third quarter of the current fiscal year were as follows: number of share acquisition rights (units), 80; number of shares underlying the share acquisition rights, 80,000; exercise payment, ¥1 per share; exercise period, 5 December 2019 to 4 December 2024.」
The company issued 80 share acquisition rights during the third quarter of the current fiscal year, covering 80,000 shares, with an exercise period from 5 December 2019 to 4 December 2024.